Efficacy of Gamification in Enhancing User Engagement

Alzheimer Disease Clinical Trial

Official title: Efficacy of Gamification in Enhancing User Engagement in Visual Mapping Assistive Technology

Status Completed

Clinical Trial Summary

As part of Phase II of the NIH SBIR grant, the study will conduct a randomized controlled clinical trial in which the MapHabit system's gamification is investigated to determine whether the assistive technology facilitates user engagement and retention. Additionally, the study will examine if the gamified software improves the quality of life of persons with dementia and reduce the burden of the respective care partners. Participants will be individuals with Alzheimer's disease or related dementias in mild to moderate stage of cognitive impairment, in tandem with their respective care partner (i.e., primary familial caregiver). The study will be a randomized controlled clinical trial, in which three conditions will be investigated: 1) experimental condition in which MHS+G is implemented into the daily care received by participants 2) control condition in which the MHS alone is incorporated into the participant's daily care 3) exploratory condition where virtual reality gamification is incorporated into the MHS+G experience. The sample size will be a total of 40 individual-caregiver dyads, 20 in each condition-5 of the 20 subjects in the experimental condition will be included in exploratory condition. The study duration will be a 6-month intervention.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Alzheimer Disease
• Dementia
• Gamification

• NCT number: NCT05422339
• Study type: Interventional
• Source: MapHabit, Inc.
• Status: Completed
• Phase: N/A
• Start date: September 12, 2022
• Completion date: September 28, 2023